BBIO · Stage, GEX levels and seasonality

BridgeBio Pharma, Inc. Common Stock (BBIO)

Last close $78.18 (+0.22%) on 2026-11-19

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Open the chart

Weinstein stage

Stage 3B — Topping · 3 weeks in this stage · 30-week average $73.05

Stage 3 (topping): the advance stalls and the 30-week average flattens.

What would change it: Stage 4 begins on a weekly close below 64.36 (the top's support) under a flat or falling 30-week SMA.

GEX levels

Put wallGamma flipCall wall
6572.775

Set before the open on 2026-11-13. Members see today's levels, updated every 15 minutes. How to read GEX.

Seasonality

MonthAverage returnMonths upYears
January+11.74%50%4
February-1.7%75%4
March+9.81%50%4
April-1.44%25%4
May-3.92%25%4
June+14%75%4
July+24.12%100%4
August+1.74%50%4
September-7.8%25%4
October+9.61%100%3
November (this month)+9.53%100%3
December+14.31%100%3

Based on up to 4 years of weekly closes. Past seasonality does not predict future returns.

On Signa plans

The Signa score and Action Card for BBIO, live options flow, dark pool prints, today's GEX levels with vanna and charm, and what 40+ AI agents say about it.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.

Questions about BBIO

What Weinstein stage is BBIO in?

BBIO is in Stage 3B — Topping, for 3 weeks, based on completed weekly bars and its 30-week moving average (73.05).

How has BBIO done in November?

Over the last 3 years, BBIO averaged +9.53% in November and rose in 100% of them. Past seasonality does not predict future returns.

What are BBIO's GEX levels?

Before the open on 2026-11-13, BBIO's put wall was 65, gamma flip 72.7 and call wall 75. Signa members see today's levels, updated every 15 minutes.

Start 7-day trial

No card. The trial ends after 7 days unless you choose a paid plan. There is no automatic charge.